| User's Publication |
|
21247
Subbiah V, Sahai V, Maglic D, Bruderek K, Toure BB, Zhao S, Valverde R, O'Hearn PJ, Moustakas DT, Schonherr H, Gerami-Moayed N, Taylor AM, Hudson BM, Houde DJ, Pal D, Foster L, Gunaydin H, Ayaz P, Sharon DA, Goyal L, Schram AM, Kamath S, Sherwin CA, Schmidt-Kittler O, Jen KY, Ricard F, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Casaletto JB.
RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations.
Cancer Discov
2023
PubMed ID: 37270847
DOI: 10.1158/2159-8290.CD-23-0475
|
|
20482
Bolatkan A, Asada K, Kaneko S, Suvarna K, Ikawa N, Machino H, Komatsu M, Shiina S, Hamamoto R.
Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules.
Int J Oncol
2022
60(1)
PubMed ID: 34913069
DOI: 10.3892/ijo.2021.5294
|
|
20679
Furuke H, Konishi H, Arita T, Kataoka S, Shibamoto J, Takabatake K, Takaki W, Shimizu H, Yamamoto Y, Morimura R, Komatsu S, Shiozaki A, Ikoma H, Otsuji E.
miR‑4730 suppresses the progression of liver cancer by targeting the high mobility group A1 pathway.
Int J Mol Med
2022
49(6)
PubMed ID: 35485281
DOI: 10.3892/ijmm.2022.5139
|
|
16500
Hamaya S, Fujihara S, Iwama H, Fujita K, Shi T, Nakabayashi R, Mizuo T, Takuma K, Nakahara M, Oura K, Tadokoro T, Mimura S, Tani J, Morishita A, Kobara H, Ono M, Himoto T, Masaki T.
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
Anticancer Res
2022
42(3):1263-1275
PubMed ID: 35220216
DOI: 10.21873/anticanres.15593
|
|
16740
Itoh G, Takagane K, Fukushi Y, Kuriyama S, Umakoshi M, Goto A, Yanagihara K, Yashiro M, Tanaka M.
Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression
Mol Oncol
2022
16(1):166-187
PubMed ID: 34379869
DOI: 10.1002/1878-0261.13077
|
|
12538
Kaneya Y, Takata H, Wada R, Kure S, Ishino K, Kudo M, Kondo R, Taniai N, Ohashi R, Yoshida H, Naito Z.
Inhibitor for protein disulfide-isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16
Oncol Lett
2021
21(1):28
PubMed ID: 33240434
DOI: 10.3892/ol.2020.12289
|
|
20105
Liang B, Zhou Y, Qian M, Xu M, Wang J, Zhang Y, Song X, Wang H, Lin S, Ren C, Monga SP, Wang B, Evert M, Chen Y, Chen X, Huang Z, Calvisi DF, Chen X.
TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
J Hepatol
2021
PubMed ID: 33577921
DOI: 10.1016/j.jhep.2021.01.044
|
|
20136
El-Mezayen H, Yamamura K, Yusa T, Nakao Y, Uemura N, Kitamura F, Itoyama R, Yamao T, Higashi T, Hayashi H, Imai K, Chikamoto A, Yamashita YI, Baba H.
MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma.
Ann Surg Oncol
2021
PubMed ID: 33886022
DOI: 10.1245/s10434-021-09778-2
|
|
14011
Wu Z, Kong X, Wang Z.
Integrin α7 knockdown suppresses cell proliferation, migration, invasion and EMT in hepatocellular carcinoma
Exp Ther Med
2021
21(4):309
PubMed ID: 33717252
DOI: 10.3892/etm.2021.9740
|
|
16100
Ogawa S, Kubo H, Murayama Y, Kubota T, Yubakami M, Matsumoto T, Yamamoto Y, Morimura R, Ikoma H, Okamoto K, Kamiya M, Urano Y, Otsuji E.
Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal
Sci Rep
2021
11(1):1794
PubMed ID: 34504174
DOI: 10.1038/s41598-021-97073-1
|
|
12545
Aiyama T, Orimo T, Yokoo H, Ohata T, Hatanaka KC, Hatanaka Y, Fukai M, Kamiyama T, Taketomi A.
Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis
PLoS One
2020
15(9):e0239462
PubMed ID: 32956413
DOI: 10.1371/journal.pone.0239462
|
|
12313
Sato Y, Yamada T, Hiroyama T, Sudo K, Hasegawa N, Hyodo I, Nakamura Y.
A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7
Cancer Sci
2019
110(5):1644-1652
PubMed ID: 30784169
DOI: 10.1111/cas.13978
|
|
13423
Zhiyong Wu, Xiaoyu Kong, Zhihui Wang
Integrin α7 knockdown suppresses cell proliferation, migration, invasion and endothelium-mesenchymal transformation in hepatocellular carcinoma
Research Square
2019
DOI: 10.21203/rs.2.18036/v1
|
|
4276
Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, Yamaguchi K, Shimosegawa T, Satoh K.
Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines.
Oncol Lett
2018
PubMed ID: 29387231
DOI: 10.3892/ol.2017.7322
|
|
5802
Eguchi T et al
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.
PLoS One
2018
13(2):e0191109.
PubMed ID: 29415026
DOI: 10.1371/journal.pone.0191109
|
|
10240
Ohata T, Yokoo H, Kamiyama T, Fukai M, Aiyama T, Hatanaka Y, Hatanaka K, Wakayama K, Orimo T, Kakisaka T, Kobayashi N, Matsuno Y, Taketomi A.
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Cancer Med
2017
6:1049-1061
PubMed ID: 28374947
DOI: 10.1002/cam4.1020
|
|
14269
Futami T, Okada H, Kihara R, Kawase T, Nakayama A, Suzuki T, Kameda M, Shindoh N, Terasaka T, Hirano M, Kuromitsu S.
ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma
Mol Cancer Ther
2017
16(1):68-7
PubMed ID: 27837028
DOI: 10.1158/1535-7163.MCT-16-0188
|
|
9574
Ferraris P, Chandra PK, Panigrahi R, Aboulnasr F, Chava S, Kurt R, Pawlotsky JM, Wilkens L, Osterlund P, Hartmann R, Balart LA, Wu T, Dash S.
Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.
Am. J. Pathol.
2016
186:938-51
PubMed ID: 26896692
DOI: 10.1016/j.ajpath.2015.11.027
|
|
9576
Sugai S, Yoshikawa T, Iwama T, Tsuchiya N, Ueda N, Fujinami N, Shimomura M, Zhang R, Kaneko S, Uemura Y, Nakatsura T.
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
Int. J. Oncol.
2016
48:1794-804
PubMed ID: 26936487
DOI: 10.3892/ijo.2016.3403
|
|
14010
Higashi T, Hayashi H, Kitano Y, Yamamura K, Kaida T, Arima K, Taki K, Nakagawa S, Okabe H, Nitta H, Imai K, Hashimoto D, Chikamoto A, Beppu T, Baba H.
Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma
Med Oncol
2016
33(11):123
PubMed ID: 27734263
DOI: 10.1007/s12032-016-0845-6
|
|
12536
Takeshi Yamada, Masato Abei, Inaho Danjoh, Ryoko Shirota, Taro Yamashita, Ichinosuke Hyodo, Yukio Nakamura
Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib
BMC Cancer
2015
15:260
PubMed ID: 25885470
DOI: 10.1186/s12885-015-1297-7
|
|
12537
Fujita K, Iwama H, Sakamoto T, Okura R, Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Yamana Y, Himoto T, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T.
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
Int J Oncol
2015
46(6):2419-30
PubMed ID: 25823465
DOI: 10.3892/ijo.2015.2941
|
|
12541
Soejima Y, Inoue M, Takahashi Y, Uozaki H, Sawabe M, Fukusato T.
ntegrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma
Hepatol Res
2014
44(14):E320-34
PubMed ID: 24552196
DOI: 10.1111/hepr.12312
|
|
12542
Suzuki R, Aruga A, Kobayashi H, Yamato M, Yamamoto M.
Development of a novel in vivo cancer model using cell sheet engineering
Anticancer Res
2014
34(9):4747-54.
PubMed ID: 25202053
|
|
12543
Kinoshita H, Okabe H, Beppu T, Chikamoto A, Hayashi H, Imai K, Mima K, Nakagawa S, Ishimoto T, Miyake K, Yokoyama N, Ishiko T, Baba H.
Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma
Oncol Rep
2013
29(2):685-9
PubMed ID: 23229496
DOI: 10.3892/or.2012.2162
|
|
12544
Kumagai A, Fukushima J, Takikawa H, Fukuda T, Fukusato T.
Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma
Hepatol Res
2013
43(9):959-69
PubMed ID: 23369163
DOI: 10.1111/hepr.12047
|
|
12539
Kawano Y, Nagata M, Kohno T, Ichimiya A, Iwakiri T, Okumura M, Arimori K.
Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells
Biol Pharm Bull
2012
35(3):400-7
PubMed ID: 22382328
DOI: 10.1248/bpb.35.400
|
|
5863
Yoshii Y, Waki A, Yoshida K, Kakezuka A, Kobayashi M, Namiki H, Kuroda Y, Kiyono Y, Yoshii H, Furukawa T, Asai T, Okazawa H, Gelovani JG, Fujibayashi Y.
The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.
Biomaterials
2011
32(26):6052-8
PubMed ID: 21640378
DOI: 10.1016/j.biomaterials.2011.04.076
|
|
12540
Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y.
RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma
Int J Mol Med
2010
25(4):537-45
PubMed ID: 20198302
DOI: 10.3892/ijmm_00000375
|
|
12546
Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K, Shinomura Y.
Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
World J Gastroenterol
2010
16(28):3521-8
PubMed ID: 20653060
DOI: 10.3748/wjg.v16.i28.3521
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
Back
Top
CELL BANK Website
